Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
Quick Stats
Jun 23, 202656.0
AI Score
HOLD0.82
Volume Ratio
Aug 05, 2026
Next Earnings
19
+ve Days (30d)
11
-ve Days (30d)
ARQT Stock Summary
Last updated Jun 23, 2026
ARQT is currently trading at $26.27, positioned above its 200-day moving average of $24.1, indicating a long-term uptrend. The stock has a 52-week range of $13.06 to $31.77.
Technical Analysis: The 50-day moving average stands at $22.85, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 69.757, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.159, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ARQT at 56.0/100 with a HOLD recommendation.
ARQT (Arcutis Biotherapeutics, Inc. Common Stock) Indicators
Last updated Jun 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 69.757 |
| CMF (20) | 0.159 |
| ROC (10) | 21.959 |
| ADX (14) | 31.524 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.224 |
| AROONOSC (14) | 100.0 |
| WILLAMS %R (14) | -13.804 |
| MFI (14) | 85.008 |
ARQT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ARQT Price vs Max Options Open Interest
ARQT Max Change In Options Open Interest
ARQT Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ARQT Daily Out of Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ARQT Daily In the Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ARQT Most Active Options by Volume(near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Arcutis Biotherapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ARQT Moving Averages Analysis
Arcutis Biotherapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 23, 2026
Arcutis Biotherapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 23, 2026
ARQT (Arcutis Biotherapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jun 23, 2026
| Days | MA |
|---|---|
| 10 | 25.16 |
| 20 | 23.25 |
| 30 | 22.45 |
| 50 | 22.85 |
| 100 | 23.76 |
| 200 | 24.1 |
ARQT Fundamental Analysis
| P/E (Forward) | 149.2537 |
| P/E (Trailing) | -- |
| Market Cap ($) | 3.3 billion |
| Earnings/Share ($) | -0.02 |
| Net Proft Margin (%) | -0.0057 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.245 |
| EPS Estimate Next Year ($) | 1.1557 |
| WallStreet Target Price ($) | 34.625 |
| Most Recent Quarter |